Single User License
INR 96330
Site License
INR 192660
Corporate User License
INR 288990

Service Tax Additional

select a format

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500


Request a quote
Request a Customized research
Request for Sample Report

Recent Viewed Reports

Why Ken Reasearch?


This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Soligenix, Inc.-Product Pipeline Review-2015

Soligenix, Inc.-Product Pipeline Review-2015

  • Products Id :- GMDHC07197CDB
  • |
  • Pages: 45
  • |
  • July 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Soligenix, Inc.-Product Pipeline Review-2015


Global Markets Direct's, 'Soligenix, Inc.-Product Pipeline Review-2015', provides an overview of the Soligenix, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Soligenix, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Soligenix, Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Soligenix, Inc.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Soligenix, Inc.'s pipeline products

Reasons To Buy

Evaluate Soligenix, Inc.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Soligenix, Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Soligenix, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Soligenix, Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Soligenix, Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Soligenix, Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Soligenix, Inc. Snapshot 5

Soligenix, Inc. Overview 5

Key Information 5

Key Facts 5

Soligenix, Inc.-Research and Development Overview 6

Key Therapeutic Areas 6

Soligenix, Inc.-Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products-Monotherapy 10

Pipeline Products-Combination Treatment Modalities 11

Soligenix, Inc.-Pipeline Products Glance 12

Soligenix, Inc.-Late Stage Pipeline Products 12

Phase III Products/Combination Treatment Modalities 12

Soligenix, Inc.-Clinical Stage Pipeline Products 13

Phase II Products/Combination Treatment Modalities 13

Phase I Products/Combination Treatment Modalities 14

Soligenix, Inc.-Early Stage Pipeline Products 15

Preclinical Products/Combination Treatment Modalities 15

Soligenix, Inc.-Drug Profiles 16

SGX-301 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

dusquetide 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

SGX-203 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

SGX-201 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

RiVax 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

RiVax + SGX-204 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

SGX-101 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

SGX-202 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

SGX-204 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

SGX-943 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

Soligenix, Inc.-Pipeline Analysis 28

Soligenix, Inc.-Pipeline Products by Target 28

Soligenix, Inc.-Pipeline Products by Route of Administration 29

Soligenix, Inc.-Pipeline Products by Molecule Type 30

Soligenix, Inc.-Pipeline Products by Mechanism of Action 31

Soligenix, Inc.-Recent Pipeline Updates 32

Soligenix, Inc.-Dormant Projects 40

Soligenix, Inc.-Discontinued Pipeline Products 41

Discontinued Pipeline Product Profiles 41


Soligenix, Inc.-Company Statement 42

Soligenix, Inc.-Locations And Subsidiaries 43

Head Office 43

Other Locations & Subsidiaries 43

Appendix 44

Methodology 44

Coverage 44

Secondary Research 44

Primary Research 44

Expert Panel Validation 44

Contact Us 44

Disclaimer 45

List of Tables

Soligenix, Inc., Key Information 5

Soligenix, Inc., Key Facts 5

Soligenix, Inc.-Pipeline by Indication, 2015 8

Soligenix, Inc.-Pipeline by Stage of Development, 2015 9

Soligenix, Inc.-Monotherapy Products in Pipeline, 2015 10

Soligenix, Inc.-Combination Treatment Modalities in Pipeline, 2015 11

Soligenix, Inc.-Phase III, 2015 12

Soligenix, Inc.-Phase II, 2015 13

Soligenix, Inc.-Phase I, 2015 14

Soligenix, Inc.-Preclinical, 2015 15

Soligenix, Inc.-Pipeline by Target, 2015 28

Soligenix, Inc.-Pipeline by Route of Administration, 2015 29

Soligenix, Inc.-Pipeline by Molecule Type, 2015 30

Soligenix, Inc.-Pipeline Products by Mechanism of Action, 2015 31

Soligenix, Inc.-Recent Pipeline Updates, 2015 32

Soligenix, Inc.-Dormant Developmental Projects,2015 40

Soligenix, Inc.-Discontinued Pipeline Products, 2015 41

Soligenix, Inc., Subsidiaries 43

List of Figures

Soligenix, Inc.-Pipeline by Top 10 Indication, 2015 7

Soligenix, Inc.-Pipeline by Stage of Development, 2015 9

Soligenix, Inc.-Monotherapy Products in Pipeline, 2015 10

Soligenix, Inc.-Pipeline by Top 10 Target, 2015 28

Soligenix, Inc.-Pipeline by Top 10 Route of Administration, 2015 29

Soligenix, Inc.-Pipeline by Top 10 Molecule Type, 2015 30

Soligenix, Inc.-Pipeline Products by Top 10 Mechanism of Action, 2015 31

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of Soligenix, Inc.; Soligenix, Inc. - Key Therapeutics; Soligenix, Inc. - Pipeline Overview and Promising Molecules; Soligenix, Inc. - News; Soligenix, Inc. - Latest Updates; Soligenix, Inc. - Pipeline; Soligenix, Inc. - Discontinued/Dormant Projects

Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204


Company Brochure

Engage with Us

query [@]